Latest AI and machine learning research in brain cancer for healthcare professionals.
BACKGROUND: The prognosis for patients with glioblastoma (GBM) remains extremely poor, a challenge largely attributable to the complex nature of its malignant progression and an insufficient understanding of the dynamic plasticity and spatial heterogeneity inherent in the tumour microenvironment during invasion. In recent years, copper has emerged as a trace element of considerable interest due to...
Neuro-cancer crosstalk plays an important role in the development and progression of Glioblastoma (GBM), but its specific mechanisms remain incompletely elucidated. This study aims to systematically identify key genes related to neuro-cancer crosstalk in GBM and construct a prognostic risk model through integrating single-cell RNA sequencing (scRNA-seq), bulk RNA-seq, and machine learning algorith...
Compact robotic systems offer new opportunities for spinal procedures outside the operating room, but their potential for small-scale interventions su...
BACKGROUND: Gliomas are increasingly understood as disorders of distributed brain networks rather than focal lesions confined within radiographic marg...
BACKGROUND AND PURPOSE: Accurate delineation of organs of interest (OOIs, also commonly referred to as organs at risk, OARs) is crucial for safe radio...
The purpose of this investigation is to assess the outcome of Oxytactic microorganism in chemical reactive flow of TiO2Â +Â GO/water based hybrid nanofl...
The century-old vision of a "magic bullet" in oncology is being realized through the paradigm of precision theranostics, which formally integrates tar...
Glioblastoma (GBM), the most aggressive primary brain tumor, develops within a tumor microenvironment (TME) dominated by tumor-associated macrophages ...
PURPOSE: Differentiating true progression (TP) from pseudoprogression (PsP) in glioma is challenging due to overlapping enhancement patterns on conven...
Large language models (LLMs) have recently gained attention for their potential. However, concerns remain regarding their reliability due to limitatio...
Lung cancer, the leading cause of death worldwide, claims millions of lives yearly, largely due to limited early interventions. Currently used lung ca...
PURPOSE: To systematically investigate the diagnostic performance of magnetic resonance imaging (MRI)-based radiomics and deep learning (DL) models fo...
Lower-grade glioma (LGG) is a highly heterogeneous disease, making accurate prognosis prediction and the development of precise, personalized treatmen...
BACKGROUND: Accurate segmentation is central for the diagnosis and treatment of gliomas. Although manual segmentation remains the clinical standard, i...
OBJECTIVE: To evaluate the effects of arm positioning and reconstruction algorithms on radiation dose and image quality of abdominal CT. MATERIALS AND...
Isocitrate dehydrogenase (IDH) is a pivotal molecular marker for glioma diagnosis, prognosis, and treatment planning. Multi-modal deep learning method...
BACKGROUND AND PURPOSE: IDH mutation & 1p/19q codeletion are critical biomarkers for glioma diagnosis & therapy. 1p/19q codeletion occurs exclusively ...
BACKGROUND: Automatic segmentation of gliomas on amino acid PET is essential for quantitative tumor assessment, a pillar in monitoring gliomas under t...
This invited commentary grew out of a presentation made at the 2025 ConRad Meeting in Munich, Germany, and summarizes talks made by researchers suppor...
Positron emission tomography (PET) has been used in pediatric oncology since the modality gained traction 20 years ago but has been used more sparingl...